Elon Musk sues OpenAI: litigation with Sam Altman begins in the US

The legal conflict between Elon Musk and Sam Altman enters a new phase: proceedings on the lawsuit against OpenAI are set to begin on April 27, 2026 in Oakland, California. Formally, the dispute concerns whether the company misled Musk, but in reality it touches on a larger story—about power, control, and the right to determine what one of the world's most influential AI companies should become. Musk was among OpenAI's co-founders, which launched as a research organization with a publicly declared mission to work for the benefit of all humanity.

Later he left the project, and OpenAI gradually shifted from the image of a laboratory to the status of a full-fledged commercial market leader. During this time, Altman became the principal architect of its strategy and the most visible face of the company. Therefore, this present dispute is perceived not simply as a lawsuit by a former co-founder against an organization, but as a deferred conflict over who owns OpenAI's original idea and who has the right to interpret its mission.

Over recent years, Musk's legal position has changed several times. Different versions of claims included accusations of breach of agreements, unfair business practices, and misleading statements. This very disparity is important: it shows that the dispute is not about one narrow deal or one contract, but about an entire chain of decisions, statements, and transformations.

For the court, this means a struggle not only over the letter of documents, but also over the interpretation of early promises, internal discussions, and OpenAI's public rhetoric at the moment when the company was still building its identity. Additional gravity to the proceedings is lent by the moment at which it begins. OpenAI remains at the center of the AI race, where at stake is not only reputation, but also access to investments, computational resources, corporate partners, and top researchers.

At the same time, Musk is building his own AI ecosystem around xAI and is effectively competing with OpenAI for market, talent, and influence. In such a situation, any episode of the proceedings—testimony, correspondence, old agreements, internal discussions within the board or management—can turn into not just a legal argument, but a tool of pressure on the rival and a signal for investors. Hence the heightened interest in who exactly will testify in court and what details will enter the public domain.

If Musk and Altman actually do testify personally, the case will quickly go beyond the bounds of an ordinary corporate dispute. The public, competitors, and regulators will follow not only the outcome of the lawsuit, but also how both sides describe the early history of OpenAI, its motivation, governance structure, and the transition to a more commercial model. At the center of attention will be not only loud statements, but also more prosaic questions: who made key decisions, how was the company's mission discussed, and where exactly did the boundary between research project and big business run.

Any discrepancies between internal discussions and public statements could deal a painful blow to reputation, even if there are no immediate legal consequences. Yet the conflict itself already looks like a concentrate of the entire industry—a mix of ideology, ambition, personal history, and very high stakes around generative AI. The principal conclusion is that this trial is important not only for OpenAI and Musk.

It could become a marker of how the market will evaluate AI company promises, their governance structure, and the boundaries between research mission and commercial interests. Even if the proceedings do not bring swift legal resolution, they already intensify pressure on the entire sector: the more capital and influence concentrated around generative AI, the fiercer will be not only technological but also personal wars between its leaders.